Dipartimento di Biologia Molecolare, Sezione
di Microbiologia, Università di Siena, I-53100
Siena,1 and Dipartimento di Scienze e
Tecnologie Biomediche, Università di L'Aquila, I-67100 Coppito,
L'Aquila,3 Italy, and Centre
d'Ingénierie des Protéines, Université de
Liège, Sart Tilman, B-4000 Liège, Belgium2
Received 10 September 1999/Returned for modification 4 January
2000/Accepted 27 February 2000
 |
INTRODUCTION |
Metallo-
-lactamases
(molecular-class B, group 3 of the functional classification
[7]) are monomeric or oligomeric proteins that require
a metal cofactor (Zn2+ in native enzymes) for activity and
are structurally and evolutionarily unrelated to active-site serine
-lactamases (6, 13). The relevance of
metallo-
-lactamases as resistance effectors is mostly due to their
substrate specificity, which always includes carbapenems and often also
cephalosporins and penicillins, and to their resistance to
mechanism-based serine
-lactamase inhibitors (6, 12, 19, 20,
26).
Several metallo-
-lactamases have been sequenced (4, 18, 26, 27,
29, 33). From a structural standpoint these enzymes appear to be
clustered into three different evolutionary lineages: subclass B1
(including most known metallo-
-lactamases), subclass B2 (including
the Aeromonas enzymes), and subclass B3 (including the
highly divergent L1 enzyme from Stenotrophomonas maltophilia) (26). From a functional standpoint most of
these enzymes exhibit a broad substrate specificity (subgroup 3a in the
functional classification), whereas the Aeromonas enzymes behave as rather specific carbapenemases (subgroup 3b in the functional classification) (6, 26).
Additional metallo-
-lactamases have been purified and partially
characterized from Myroides odoratus (formerly
Flavobacterium odoratum) (30),
Legionella (Fluoribacter) gormanii
(14), and Burkholderia cepacia (3),
but their definitive attribution to molecular-class B awaits the
confirmation of sequence data. Among these, the enzyme of L. gormanii exhibits distinctive biochemical properties compared to
other metallo-
-lactamases, with preferential activity for
cephalosporin compounds (14). This warranted its inclusion
in a further subgroup (subgroup 3c) of the functional classification
(6, 26).
In this study we cloned and characterized a metallo-
-lactamase
determinant from L. gormanii ATCC 33297T, whose
product overall resembles the enzyme that was previously purified from
this strain (14). Sequencing revealed that the L. gormanii metallo-
-lactamase is a new member of the highly divergent subclass B3 lineage of class B
-lactamases.
(These results were presented in part at the 39th Interscience
Conference on Antimicrobial Agents and Chemotherapy, 1999.)
 |
MATERIALS AND METHODS |
Bacterial strains and genetic vectors.
L. gormanii
ATCC 33297T was used as the donor strain for construction
of the genomic library. Escherichia coli DH5
(Gibco-BRL, Bethesda, Md.) was used as the host for genetic vectors and recombinant plasmids. E. coli BL21(DE3)(pLysS) (Novagen Inc., Madison,
Wis.) was used as a host for overexpression of the L. gormanii
blaFEZ-1 gene cloned in the expression vector pET-24.
Plasmid pACYC184 (10) was used as the vector for
construction of the L. gormanii genomic library. Plasmid
pBC-SK (Stratagene, La Jolla, Calif.) was used for some subcloning
steps. Plasmid pET-24 (Novagen) was used as a T7-based vector for
tightly regulated overexpression of the blaFEZ-1
gene in E. coli.
Antibiotics and
-lactamase substrates.
Antibiotics were
obtained from Sigma Chemical Co. (St. Louis, Mo.) unless otherwise
specified. Imipenem and cefoxitin were from Merck Research Laboratories
(Rahway, N.J.), meropenem was from Zeneca Pharmaceuticals
(Macclesfield, Cheshire, United Kingdom), cefuroxime and ceftazidime
were from Glaxo-Wellcome (Verona, Italy), cefotaxime was from
Hoechst-Marion-Roussel (Frankfurt, Germany), and aztreonam was from
Bristol-Myers Squibb Co. (Wallingford, Conn.). Nitrocefin was from
Unipath (Milan, Italy).
In vitro susceptibility testing.
In vitro susceptibility of
the E. coli clone carrying the cloned
blaFEZ-1 metallo-
-lactamase determinant was
determined by a broth macrodilution method (22), using
Mueller-Hinton medium (Difco Laboratories, Detroit, Mich.) and a
bacterial inoculum of 105 CFU per tube. Results were
recorded after incubation at 28°C for 24 h.
-Lactamase assays.
-Lactamase activity in crude
E. coli cell extracts was assayed spectrophotometrically.
Reactions were performed in phosphate-buffered saline (PBS), pH 7.3, at
25°C, in a total volume of 0.75 ml. The initial substrate
concentrations were 100 µM for cephalosporins, 150 µM for
carbapenems, and 1 mM for penicillins. For the indicated compounds,
wavelengths and changes in the extinction coefficient, respectively,
were as follows: imipenem, 299 nm and
9,000 M
1
cm
1; meropenem, 297 nm and
6,500 M
1
cm
1; nitrocefin, 482 nm and +15,000 M
1
cm
1; cefuroxime, 260 nm and
7,600 M
1
cm
1; cefotaxime, 260 nm and
7,500 M
1
cm
1; cefoxitin, 260 nm and
7,800 M
1
cm
1; penicillin G, 235 nm and
800 M
1
cm
1; and ampicillin, 235 nm and
820 M
1
cm
1. Inhibition of enzymatic activity by EDTA or
dipicolinic acid was determined by measuring the residual activity
after incubation of the crude extract, for 15 min at 25°C, in the
presence of variable concentrations of each chelating agent. Crude cell
extracts were prepared as follows. Cells were grown in Luria-Bertani
broth (28) aerobically at 28°C, collected by
centrifugation, resuspended in PBS (1/10 of the original culture
volume), and disrupted by sonication (six times for 15 s each, at
50 W). The supernatant obtained after centrifugation at
10,000 × g for 10 min, to remove cell debris,
represented the crude extract. Protein concentration in solution was
determined with a commercial protein assay kit (Bio-Rad, Richmond,
Calif.) with bovine serum albumin as a standard.
Protein analysis techniques.
Analytical isoelectric focusing
(IEF) of crude cell extracts was performed in precast 5%
polyacrylamide gels containing ampholites (pH range, 3.5 to 9.5)
(Ampholine PAGplate; Amersham Pharmacia Biotech, Uppsala, Sweden) using
a Multiphor II Apparatus (Pharmacia). Gels were focused at 0.1 W/cm2 for 2 h at 10°C.
-Lactamases were detected
as pink bands after overlaying the gel with filter paper soaked with a
0.25 mM nitrocefin solution in 30 mM ACES
[N-(2-acetamido)-2-aminoethanesulfonic acid]-NaOH buffer,
pH 7.0, supplemented with 2 mM ZnCl2. Zymogram detection of
-lactamase activity after sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) of protein preparations was performed essentially as previously described (21). After the initial renaturation treatment, the gel was equilibrated in PBS for 20 min at
37°C, and
-lactamase activity was revealed by the appearance of
pink bands after overlaying the gel with filter paper soaked with a
0.25 mM nitrocefin solution in PBS.
Recombinant DNA methodology.
Basic recombinant DNA
procedures were performed essentially as described by Sambrook et al.
(28). Extraction of the genomic DNA from L. gormanii was performed as described previously (16) from cells grown on BCYE
agar plates (Oxoid Ltd., Basingstoke, United Kingdom) at 37°C in an aerobic atmosphere enriched with 5%
CO2. For construction of the library, genomic DNA was
partially digested with Sau3AI, and fragments in the 4- to
12-kb size range were purified by agarose gel electrophoresis using the
Geneclean II kit (Bio-101, La Jolla, Calif.). The purified restriction
fragments were ligated to BamHI-linearized and
dephosphorylated pACYC184 vector, and the ligation mixture was used to
transform E. coli DH5
by electroporation using a Gene
Pulser apparatus (Bio-Rad) according to the manufacturer's
instructions. The ratio of recombinant clones to those carrying an
empty religated vector was >5, as shown by replica plating of
transformants onto plates containing both chloramphenicol (85 µg/ml)
and tetracycline (20 µg/ml). The system for overexpression of the
blaFEZ-1 gene in E. coli was prepared
as follows. The blaFEZ-1 open reading frame
(ORF) and some downstream region were amplified by PCR using primers
BLAFEZ-FN (5'-GGAATTCCATATGAAAAAAGTATTAAGTTTAAC),
which added an NdeI linker overlapping the
blaFEZ-1 start codon (in boldface type), and
BLAFEZ-RB (5'-GCGGATCCTTTGACCAATATG), which was designed 0.35 kb downstream of the blaFEZ-1 stop codon
and contained a BamHI linker. The 1.2-kb amplimer was
digested with BamHI, cloned in plasmid pBC-SK digested with
BamHI and EcoRV (the resulting recombinant
plasmid was named pBLL/FEZ1), and subjected to confirmatory sequencing.
The 1.2-kb NdeI-BamHI fragment of pBLL/FEZ1 was
then subcloned in pET-24, and the resulting recombinant plasmid, named pET-24/FEZ1, was transformed into E. coli BL21(DE3)(pLysS).
The expression experiments with E. coli
BL21(DE3)(pLysS)(pET-24/FEZ1) were performed in duplicate. In these
experiments the strain was grown aerobically at 28°C in Luria-Bertani
medium containing chloramphenicol (70 µg/ml) and kanamycin (50 µg/ml). For induction,
isopropyl-
-D-thiogalactopyranoside (IPTG) was added at a
0.5 mM final concentration when the culture turbidity achieved an
A600 of 0.8 to 0.9.
DNA sequencing and computer analysis of sequence data.
DNA
sequences were determined by the dideoxy-chain termination method using
an automatic DNA sequencer (LICOR 4000; LI-COR Inc., Lincoln, Nebr.),
the Thermosequenase DNA sequencing kit (Amersham), and IRD 800-labeled
custom sequencing primers (MWG-Biotech, Munich, Germany). Sequences
were determined on both strands, using denatured double-stranded DNA
templates. Similarity searches against sequence databases were
performed using an updated version of the BLAST program (1).
Computer analysis of sequence data was performed using an updated
version (8.1) of the Wisconsin Package (version 8.1; Genetics Computer
Group Inc., Madison, Wis.) available at the Italian EMBL node of Bari.
Multiple sequence alignments were generated with the help of the PILEUP
program of the Genetics Computer Group package and manually refined
considering the information available on the three-dimensional
structures of the Bc-II, CcrA, and L1 enzymes (8, 9, 11,
31).
Gel permeation chromatography.
Gel permeation chromatography
was performed on a Superdex-75 column (1 by 30 cm; Pharmacia). The
column was equilibrated and eluted in 10 mM sodium cacodylate buffer,
pH 6.5, containing 0.2 M NaCl, and calibrated by determining the
retention volume of different protein standards. The proteins were
eluted at a flow rate of 1 ml/min, and the absorbance at 280 nm was
recorded. A crude extract containing the FEZ-1 protein (300 µl), prepared from an induced culture of E. coli
BL21(DE3)(pLysS)(pET-24/FEZ1), was eluted at the same
flow rate. Fractions of 1 ml were collected, and the presence of the
-lactamase activity was monitored by testing for cefuroxime hydrolysis.
Nucleotide sequence accession number.
The nucleotide
sequence reported in this paper has been submitted to the
EMBL/GenBank/DDBJ sequence databases and assigned the accession no.
Y17896.
 |
RESULTS |
Cloning of a metallo-
-lactamase determinant from L. gormanii ATCC 33297T.
A metallo-
-lactamase
determinant was isolated from a genomic library of L. gormanii ATCC 33297T constructed in the pACYC184
plasmid vector and transformed in E. coli DH5
, by
screening for clones showing a reduced susceptibility to imipenem. For
this purpose, individual clones grown on a medium containing only
chloramphenicol (for vector selection) were replica plated onto a
medium containing chloramphenicol plus imipenem (5 µg/ml). One clone
growing on this medium (clone 8AI) was isolated out of approximately
15,000 screened recombinants. Growth of this clone on the
imipenem-containing medium was very slow, with colonies 1 mm in
diameter being visible only after 4 to 5 days of incubation at 28°C.
Measurement of the
-lactamase activity present in the crude extract
of clone 8AI showed an increased hydrolytic activity against
carbapenems and nitrocefin compared to the basal levels observed with
the parent E. coli strain. Specific activity with meropenem
was higher than that with imipenem (Table
1). The carbapenemase activity present in
the crude extract was inhibited by EDTA and dipicolinic acid, with 50%
inhibitory concentrations of 1 and 0.01 mM, respectively, suggesting a
metal-dependent nature for the enzyme.
View this table:
[in this window]
[in a new window]
|
TABLE 1.
-Lactamase activity in the crude extract of clone 8AI
(DH5 [pLLB-8AI]) with nitrocefin (NCF), imipenem (IMI), and
meropenem (MEM)a
|
|
IEF analysis of the crude extract of clone 8AI yielded a band of
-lactamase activity focusing at pH 7.6, which was not detectable in
the parent E. coli strain (results not shown). A zymogram
analysis of the crude extract, performed after renaturing SDS-PAGE,
yielded a band of
-lactamase activity at approximately 30 kDa which
was not detectable in the parent E. coli strain (Fig.
1).

View larger version (50K):
[in this window]
[in a new window]
|
FIG. 1.
Results of zymogram analysis performed after renaturing
SDS-PAGE using the chromogenic cephalosporin nitrocefin as the
substrate for detection of -lactamase activity. Protein size
standards (in kilodaltons) are indicated on the left. Lanes: 1, crude
extract from E. coli DH5 (pACYC184); 2, crude extract from
E. coli DH5 (pLLB-8AI).
|
|
Restriction mapping of the recombinant plasmid harbored by clone 8AI,
named pLLB-8AI, revealed the presence of a 4.3-kb DNA insert.
Subcloning analysis showed that the
-lactamase determinant was
apparently located within a 2.2-kb BamHI-EcoRV
fragment (Fig. 2). The origin of the
cloned
-lactamase determinant from the chromosome of L. gormanii ATCC 33297T was confirmed by Southern blot
experiments in which the 2.7-kb BamHI insert of plasmid
pLLB-27B (Fig. 2) was probed against the Legionella genomic
DNA. The probe hybridized with the band of undigested chromosomal DNA,
with a single restriction fragment of 7.9 kb after digestion with
BamHI and with two restriction fragments of 8.8 and 1.5 kb,
respectively, after digestion with EcoRV (data not shown).

View larger version (9K):
[in this window]
[in a new window]
|
FIG. 2.
Physical map of the insert of plasmid pLLB-8AI and
subcloning strategy. Thick lines represent cloned DNA, while thin lines
correspond to vector sequences. Production of metallo- -lactamase
activity ( -lact.) was assayed on crude extracts prepared from cells
collected in the late-exponential phase of growth
(A600, 1.5 to 1.8), using meropenem as the
substrate. The location of the blaFEZ-1 ORF is
also indicated. The BamHI site labeled with an asterisk was
generated after cloning of the Sau3AI genomic DNA fragment
in the BamHI site of the plasmid vector and is not present
in the Legionella chromosomal DNA, as indicated by the
results of Southern blot experiments (see text). Abbreviations for
restriction enzymes: B, BamHI; B/S,
BamHI/Sau3AI junction; H, HindIII;
Hc, HincII; Sa, SalI; V, EcoRV; X,
XbaI.
|
|
Sequence of the cloned metallo-
-lactamase determinant.
The
2.7-kb insert of plasmid pLLB-27B (Fig. 2) was sequenced. Analysis of
sequence data revealed the presence of an 849-bp ORF (Fig.
3) encoding a protein which, in a BLAST
search, showed the highest sequence similarity (29.3% identical
residues) with the L1 enzyme of S. maltophilia and weaker
similarities with other class B
-lactamases. Results of subcloning
experiments (Fig. 2) were consistent with the identification of this
ORF as the metallo-
-lactamase determinant, which was named
blaFEZ-1. The blaFEZ-1
ORF encodes a 282-amino-acid polypeptide whose amino-terminal sequence
exhibits features typical of procaryotic signal peptides targeting
protein secretion into the periplasmic space via the general secretory
pathway (Fig. 3). According to known patterns (24), the
cleavage site could be located after the Ser-17 residue. In this case
the calculated molecular mass and pI value of the mature protein would
be 29,567 Da and 7.71, respectively, which are in agreement with the
results of analytical IEF and of zymograms performed after renaturing
SDS-PAGE (see above). The low G+C content of the
blaFEZ-1 ORF (37.8%) is consistent with the
average values reported for the genomes of Legionellaceae
(5).

View larger version (46K):
[in this window]
[in a new window]
|
FIG. 3.
Nucleotide sequence of the
blaFEZ-1 ORF and flanking regions. The
initiation codon of the blaFEZ-1 ORF is
indicated, and protein translation is reported below the sequence. The
putative signal peptide for protein secretion is underlined. An
inverted repeat overlapping the termination codon of the
blaFEZ-1 gene, possibly functioning as a
transcriptional terminator, is overlined by arrows.
|
|
Comparison of the FEZ-1 enzyme with other
metallo-
-lactamases.
A multiple sequence alignment analysis
with other class B
-lactamases confirmed the closest similarity of
the L. gormanii FEZ-1 enzyme with the S. maltophilia metallo-
-lactamase. FEZ-1 and L1 could be aligned
over the entire sequence without introducing major gaps (Fig.
4), and the percent identity between the
two (29.7%) was considerably higher than those between FEZ-1 and the other class B enzymes (Table 2). Compared
to L1, the major differences of FEZ-1 are represented by the absence of
the N-terminal 310 helix region that, in L1, is positioned
prior to
1, and by an insertion within the C-terminal
5 helix
which, in L1, is already considerably elongated in comparison with
Bc-II and CcrA (31) (Fig. 4).

View larger version (47K):
[in this window]
[in a new window]
|
FIG. 4.
Comparison of the FEZ-1 amino acid sequence (in boldface
type) with those of other molecular-class B -lactamases. The
numbering scheme refers to the L1 enzyme (31). Identical
residues are indicated by an asterisk. Residues of the L1 enzyme
involved in binding of Zn2+ are indicated by a z, and those
involved in inter-subunit interactions are underlined (31).
Secondary structure elements of Bc-II (9) are also
indicated, above the sequences. Abbreviations: IMP-1, IMP-1 enzyme
encoded by the blaIMP gene cassette found in
Serratia marcescens TN9106 (23) and in other
gram-negative strains (2, 17); CcrA, CcrA enzyme of
Bacteroides fragilis TAL3636 (25); Bc-II,
-lactamase II of Bacillus cereus 569/H (15);
VIM-1, VIM-1 enzyme encoded by the blaVIM gene
cassette found in Pseudomonas aeruginosa VR-143/97
(18); IND-1, IND-1 enzyme of Chryseobacterium
indologenes 001 (4); BlaB, BlaB enzyme of
Chryseobacterium meningosepticum CCUG4310 (27);
CphA, CphA enzyme of Aeromonas hydrophila AE036
(21); L1, L1 enzyme of S. maltophilia IID 1275 (32).
|
|
Of the six invariant residues shared by the other class B enzymes
(His-86, Asp-88, Gly-91, His-160, Gly-195, and His-225, in the
numbering of the L1 enzyme of S. maltophilia IID 1275 [31]), four (His-86, Asp-88, His-160, and His-225) are
conserved also in FEZ-1, while Gly-91 and Gly-195 are replaced by an
alanine and an aspartate residue, respectively. All the residues known to be involved in Zn2+ binding in the L1 enzyme (His-84,
His-86, Asp-88, His-89, His-160, and His-225 [31]) are
conserved in the Legionella enzyme. At position 185, FEZ-1
contains a serine residue, similar to the L1 enzyme but unlike the
enzymes of molecular subclasses B1 and B2 (Fig. 4).
Patterns of
-lactam susceptibility of E. coli
producing the L. gormanii metallo-
-lactamase.
The
susceptibility to several
-lactams of E. coli
DH5
(pLLB-8AI), which carries the cloned
blaFEZ-1 determinant and produces the enzyme
(Fig. 2), was compared to that of the same E. coli host
carrying an empty vector.
Production of the FEZ-1 enzyme was associated with a decrease of the in
vitro susceptibility to various cephalosporins (including cephalothin,
cefoxitin, cefuroxime, cefotaxime, and ceftazidime) and meropenem. The
susceptibility to imipenem was only slightly affected, and that to
penicillins and aztreonam was apparently unaffected (Table
3). The above results suggested a marked
preferential activity of the FEZ-1 enzyme for cephalosporins and
meropenem. The ability of DH5
(pLLB-8AI) to grow (albeit very slowly)
on the medium used to screen the library, containing imipenem at a
higher concentration (5 µg/ml) than the MIC, was likely due to the
larger bacterial inoculum used in the replica plating procedure and to
the intrinsic poor stability of imipenem contained in the medium.
View this table:
[in this window]
[in a new window]
|
TABLE 3.
In vitro susceptibility to various -lactams of
E. coli DH5 (pLLB-8AI), which contains the cloned
blaFEZ-1 determinant, and of E. coli
DH5 carrying the empty vector
|
|
Overexpression of the blaFEZ-1 determinant
in E. coli.
A system for overexpression of the
blaFEZ-1 gene in E. coli was
developed. In preliminary experiments, the use of expression systems
based on the strong T7 phage promoter but characterized by relatively
high basal levels of expression of the heterologous gene yielded
unstable clones that eventually contained rearranged vectors and did
not overproduce the enzyme. Therefore, a tightly regulated expression
system was used in which the blaFEZ-1 gene was
cloned in the pET-24 vector and the resulting plasmid, pET-24/FEZ1, was
introduced into the E. coli host BL21(DE3)(pLysS). Using
this system, production of the FEZ-1 enzyme was detectable only upon induction with IPTG. In cell extracts prepared from induced
cultures, the meropenem-hydrolyzing activity achieved a value of
377 ± 19 pmol/min/µg of protein at 2 h after induction,
retained a similar value (383 ± 21 pmol/min/µg of protein) at
5 h after induction, and was found to be consistently decreased
(107 ± 6 pmol/min/µg of protein) after 24 h, whereas in
cell extracts prepared from uninduced cultures it remained lower than 5 pmol/min/µg of protein during the same time course. Interestingly, at
24 h after induction, a consistent amount of
-lactamase
activity was detected in the culture supernatant, revealing that a
progressive leakage of the enzyme in the medium occurred during
prolonged growth. In fact, the global amount of activity present in the
culture was found to be maximal at 24 h after induction (Fig.
5). In analytical IEF and renaturing
SDS-PAGE experiments, the
-lactamase activity produced by E. coli BL21(DE3)(pLysS)(pET-24/FEZ1) was apparently identical to
that produced by DH5
(pLLB-8AI) (data not shown).

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 5.
-Lactamase activity measured in different fractions
of a culture of E. coli BL21(DE3)(pLysS)(pET-24/FEZ1) at
different times after induction with IPTG. Activities were assayed
using meropenem as the substrate and are relative to culture volumes.
, activity in the cell fraction; , activity in the
culture supernatant.
|
|
Relative hydrolysis rates, measured with a crude cell extract prepared
from an induced culture of E. coli
BL21(DE3)(pLysS)(pET-24/FEZ1), were as follows: nitrocefin,
100; cefuroxime, 206; cefoxitin, 105; cefotaxime, 71; meropenem, 33;
imipenem, 7; penicillin G, 9; and ampicillin, 3.
In experiments of gel permeation chromatography performed with a crude
FEZ-1 preparation from E. coli
BL21(DE3)(pLysS)(pET-24/FEZ1), an Mr of
30,000 was calculated for the metallo-
-lactamase activity, suggesting that the native FEZ-1 enzyme is found in a monomeric form
(data not shown).
 |
DISCUSSION |
Results of this study showed that L. gormanii ATCC
33297T carries an apparently resident class B
-lactamase
determinant whose product exhibits a distinctive preference for
cephalosporin substrates. A similar feature remains as yet unique among
class B enzymes (4, 6, 18, 26, 27) and reinforces the notion
that considerable functional heterogeneity can be encountered among members of this class.
Sequencing of the cloned determinant revealed that its product is a new
member of the highly divergent subclass B3 lineage, which thus far has
included only one member, namely, the L1 enzyme of S. maltophilia (6, 26). The degree of sequence similarity between FEZ-1 and L1, which approaches 30% identical residues, suggests that the three-dimensional folding of the FEZ-1 molecule is
probably very similar to that recently described for L1
(31). Moreover, the complete conservation of the residues
that in L1 are known to be directly or indirectly involved in
coordination of the two zinc ions suggests that the geometry of zinc
coordination in the active site of FEZ-1 is the same as that in L1,
being different from that observed in Bc-II and CcrA (8, 9, 11,
31). Since the two cysteine residues that in L1 (at positions 218 and 246) contribute an intramolecular disulfide bridge unique among class B enzymes (31) are conserved in FEZ-1, a similar
disulfide bridge is likely to be retained also in the latter molecule.
One of the major differences between FEZ-1 and L1 is represented by the
absence, in the former, of the long N-terminal region which, in L1,
plays a prominent role in providing the interactions between the A and
C and between the B and D subunits (31). This difference could be responsible for the monomeric rather than oligomeric structure
of the native FEZ-1 enzyme, although other differences found at
positions that in L1 are known to participate in the subunit assembly
(31) (Fig. 4) could also provide a contribution in this sense.
Results of this work also indicated that the
blaFEZ-1 gene can be expressed in E. coli, resulting in a functional product. Overproduction of the
enzyme in E. coli, however, was found to be difficult using
expression systems that are characterized by a high-level basal
expression of the heterologous gene, and such overproduction could be
obtained only with a tightly regulated expression system. This system
could facilitate production of consistent amounts of the FEZ-1 enzyme,
which, owing to its unique features, appears to be an interesting
candidate for further structural and enzymological investigations. An
analysis of the kinetic parameters of FEZ-1 with a broad array of
-lactam substrates and with various chelating agents and other
inhibitors is currently under way.
We also thank Jean Denis Docquier for helpful discussions and
acknowledge the excellent technical support of Michela Cappelli and
Tiziana Di Maggio.
| 1.
|
Altschul, S. F.,
T. L. Madden,
A. A. Schaffer,
J. Zhang,
Z. Zhang,
W. Miller, and D. J. Lipman.
1997.
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.
Nucleic Acids Res.
25:3389-3402[Abstract/Free Full Text].
|
| 2.
|
Arakawa, Y.,
M. Murakami,
K. Suzuki,
H. Ito,
R. Wacharotayankun,
S. Ohsuka,
N. Kato, and M. Ohta.
1995.
A novel integron-like element carrying the metallo- -lactamase gene blaIMP.
Antimicrob. Agents Chemother.
39:1612-1615[Abstract].
|
| 3.
|
Baxter, I. A., and P. A. Lambert.
1994.
Isolation and partial purification of a carbapenem-hydrolysing metallo- -lactamase from Pseudomonas cepacia.
FEMS Microbiol. Lett.
122:251-256[Medline].
|
| 4.
|
Bellais, S.,
S. Leotard,
L. Poirel,
T. Naas, and P. Nordmann.
1999.
Molecular characterization of a carbapenem-hydrolysing -lactamase from Chryseobacterium (Flavobacterium) indologenes.
FEMS Microbiol. Lett.
171:127-132[Medline].
|
| 5.
|
Brenner, D. J.,
J. C. Feeley, and R. E. Weaver.
1984.
Family VII. Legionellaceae, p. 279.
In
N. R. Krieg, and J. G. Holt (ed.), Bergey's manual of systematic bacteriology, vol. 1. The William & Wilkins Co., Baltimore, Md.
|
| 6.
|
Bush, K.
1998.
Metallo- -lactamases: a class apart.
Clin. Infect. Dis.
27:S48-S53.
|
| 7.
|
Bush, K.,
G. A. Jacoby, and A. A. Medeiros.
1995.
A functional classification scheme for -lactamases and its correlation with molecular structure.
Antimicrob. Agents Chemother.
39:1211-1233[Medline].
|
| 8.
|
Carfi, A.,
E. Duée,
M. Galleni,
J.-M. Frère, and O. Dideberg.
1998.
1.85 Å resolution structure of the zinc(II) -lactamase from B. cereus.
Acta Crystallog. Sect. D
54:313-323.
|
| 9.
|
Carfi, A.,
S. Pares,
E. Duée,
M. Galleni,
C. Duez,
J.-M. Frère, and O. Dideberg.
1995.
The 3-D structure of a zinc metallo- -lactamase from Bacillus cereus reveals a new type of protein fold.
EMBO J.
14:4914-4921[Medline].
|
| 10.
|
Chang, A. C., and S. N. Cohen.
1978.
Construction and characterization of amplifiable multicopy DNA cloning vehicles derived from the P15A cryptic miniplasmid.
J. Bacteriol.
134:1141-1156[Abstract/Free Full Text].
|
| 11.
|
Concha, N.,
B. A. Rasmussen,
K. Bush, and O. Herzberg.
1996.
Crystal structure of the wide-spectrum binuclear zinc -lactamase from Bacteroides fragilis.
Structure
4:823-836[Medline].
|
| 12.
|
Felici, A.,
G. Amicosante,
A. Oratore,
R. Strom,
P. Ledent,
B. Joris,
L. Fanuel, and J.-M. Frère.
1993.
An overview of the kinetic parameters of class B -lactamases.
Biochem. J.
291:151-155.
|
| 13.
|
Frère, J. M.
1995.
Beta-lactamases and bacterial resistance to antibiotics.
Mol. Microbiol.
16:385-395[Medline].
|
| 14.
|
Fujii, T.,
K. Sato,
K. Miyata,
M. Inoue, and S. Mitsuhashi.
1986.
Biochemical properties of -lactamase produced by Legionella gormanii.
Antimicrob. Agents Chemother.
29:925-926[Abstract/Free Full Text].
|
| 15.
|
Hussain, M.,
A. Carlino,
M. J. Madonna, and J. O. Lampen.
1985.
Cloning and sequencing of the metallothioprotein -lactamase II gene of Bacillus cereus 569/H in Escherichia coli.
J. Bacteriol.
164:223-229[Abstract/Free Full Text].
|
| 16.
|
Johnson, J. L.
1994.
Similarity analysis of DNAs, p. 655-682.
In
P. Gerhardt, R. G. E. Murray, W. A. Wood, and N. R. Krieg (ed.), Methods for general and molecular bacteriology. American Society for Microbiology, Washington, D.C.
|
| 17.
|
Laraki, N.,
M. Galleni,
I. Thamm,
M. L. Riccio,
G. Amicosante,
J.-M. Frère, and G. M. Rossolini.
1999.
Structure of In31, a blaIMP-containing Pseudomonas aeruginosa integron phyletically related to In5, which carries an unusual array of gene cassettes.
Antimicrob. Agents Chemother.
43:890-901[Abstract/Free Full Text].
|
| 18.
|
Lauretti, L.,
M. L. Riccio,
A. Mazzariol,
G. Cornaglia,
G. Amicosante,
R. Fontana, and G. M. Rossolini.
1999.
Cloning and characterization of blaVIM, a new integron-borne metallo- -lactamase gene from a Pseudomonas aeruginosa clinical isolate.
Antimicrob. Agents Chemother.
43:1584-1590[Abstract/Free Full Text].
|
| 19.
|
Livermore, D. M.
1995.
-Lactamases in laboratory and clinical resistance.
Clin. Microbiol. Rev.
8:557-584[Abstract].
|
| 20.
|
Livermore, D. M., and J. D. Williams.
1996.
-Lactams: mode of action and mechanisms of bacterial resistance, p. 502-578.
In
V. Lorian (ed.), Antibiotics in laboratory medicine, 4th ed. The William & Wilkins Co., Baltimore, Md.
|
| 21.
|
Massidda, O.,
G. M. Rossolini, and G. Satta.
1991.
The Aeromonas hydrophyla cphA gene: molecular heterogeneity among metallo- -lactamases.
J. Bacteriol.
173:4611-4617[Abstract/Free Full Text].
|
| 22.
|
National Committee for Clinical Laboratory Standards.
1997.
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4th ed.
Approved standard. NCCLS document M7-A4. National Committee for Clinical Laboratory Standards, Wayne, Pa.
|
| 23.
|
Osano, E.,
Y. Arakawa,
R. Wacharotayankun,
M. Ohta,
T. Horii,
H. Ito,
F. Yoshimura, and N. Kato.
1994.
Molecular characterization of an enterobacterial metallo- -lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance.
Antimicrob. Agents Chemother.
38:71-78[Abstract/Free Full Text].
|
| 24.
|
Pugsley, A. P.
1993.
The complete general secretory pathway in gram-negative bacteria.
Microbiol. Rev.
57:50-108[Abstract/Free Full Text].
|
| 25.
|
Rasmussen, B. A.,
Y. Gluzman, and F. P. Tally.
1990.
Cloning and sequencing of the class B -lactamase gene (ccrA) from Bacteroides fragilis TAL3636.
Antimicrob. Agents Chemother.
34:1590-1592[Abstract/Free Full Text].
|
| 26.
|
Rasmussen, B. A., and K. Bush.
1997.
Carbapenem-hydrolyzing -lactamases.
Antimicrob. Agents Chemother.
41:223-232[Medline].
|
| 27.
|
Rossolini, G. M.,
N. Franceschini,
M. L. Riccio,
P. S. Mercuri,
M. Perilli,
M. Galleni,
J.-M. Frère, and G. Amicosante.
1998.
Characterization and sequence of the Chryseobacterium (Flavobacterium) meningosepticum carbapenemase: a new molecular class B -lactamase showing a broad substrate profile.
Biochem. J.
332:145-152.
|
| 28.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 29.
|
Sanschagrin, F.,
J. Dufresne, and R. C. Levesque.
1998.
Molecular heterogeneity of the L-1 metallo- -lactamase family from Stenotrophomonas maltophilia.
Antimicrob. Agents Chemother.
42:1245-1248[Abstract/Free Full Text].
|
| 30.
|
Sato, K.,
T. Fujii,
R. Okamoto,
M. Inoue, and S. Mitsuhashi.
1985.
Biochemical properties of -lactamase produced by Flavobacterium odoratum.
Antimicrob. Agents Chemother.
27:612-614[Abstract/Free Full Text].
|
| 31.
|
Ullah, J. H.,
T. R. Walsh,
I. A. Taylor,
D. C. Emery,
C. S. Verma,
S. J. Gamblin, and J. Spencer.
1998.
The crystal structure of the L1 metallo- -lactamase from Stenotrophomonas maltophilia at 1.7 Å resolution.
J. Mol. Biol.
284:125-136[CrossRef][Medline].
|
| 32.
|
Walsh, T. R.,
L. Hall,
S. J. Assinder,
W. W. Nichols,
S. J. Cartwright,
A. P. MacGowan, and P. M. Bennet.
1994.
Sequence analysis of the L1 metallo- -lactamase from Xanthomonas maltophilia.
Biochim. Biophys. Acta
1218:199-201[Medline].
|
| 33.
|
Walsh, T. R.,
W. A. Neville,
M. H. Haran,
D. Tolson,
D. J. Payne,
J. H. Bateson,
A. P. MacGowan, and P. M. Bennett.
1998.
Nucleotide and amino acid sequences of the metallo- -lactamase, ImiS, from Aeromonas veronii bv. sobria.
Antimicrob. Agents Chemother.
42:436-439[Abstract/Free Full Text].
|